In such a situation, we tried to clarify what mechanism works in the pathogenesis involving the gene abnormalities of HER2, KRAS, FGFR2, MET, EGFR, PI3K, BRAF, and so on in GC. This evidence concerns the gene ERBB2 and gastric cancer.